We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

61 hedge funds and large institutions have $128M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

3% more funds holding

Funds holding: 59 → 61 (+2)

3% less capital invested

Capital invested by funds: $133M → $128M (-$4.41M)

Holders
61
Holders Change
+2
Holders Change %
+3.39%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
17
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$913K
2
BCM
Bridgeway Capital Management
Texas
+$811K
3
Wells Fargo
Wells Fargo
California
+$685K
4
BlackRock
BlackRock
New York
+$661K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$199K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$710K
2
Millennium Management
Millennium Management
New York
-$451K
3
JP Morgan Chase
JP Morgan Chase
New York
-$366K
4
Citadel Advisors
Citadel Advisors
Florida
-$248K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$154K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$181K – – –
VF
27
Virtu Financial
New York
$173K +$195K +23,721 New
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$166K – – –
TI
29
Trexquant Investment
Connecticut
$116K +$131K +15,941 New
HSBC Holdings
30
HSBC Holdings
United Kingdom
$108K -$3.23K -392 -3%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$97K +$1.44K +175 +1%
Squarepoint
32
Squarepoint
New York
$94K +$107K +12,954 New
IWM
33
IHT Wealth Management
Illinois
$82K – – –
Deutsche Bank
34
Deutsche Bank
Germany
$78K -$8.29K -1,007 -9%
RJA
35
Raymond James & Associates
Florida
$76K +$86.2K +10,474 New
TYCC
36
Texas Yale Capital Corp
Florida
$73K +$82.3K +10,000 New
Morgan Stanley
37
Morgan Stanley
New York
$66K -$121K -14,671 -62%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$42K – – –
UBS Group
39
UBS Group
Switzerland
$28K +$6.3K +766 +25%
TRCT
40
Tower Research Capital (TRC)
New York
$23K +$9.93K +1,207 +62%
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$15.3K -$8.05K -979 -32%
US Bancorp
42
US Bancorp
Minnesota
$15K – – –
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$15K +$4.34K +528 +34%
Legal & General Group
44
Legal & General Group
United Kingdom
$14K -$782 -95 -5%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$11K -$17K -2,071 -55%
EWM
46
Endurance Wealth Management
Rhode Island
$11K – – –
Citigroup
47
Citigroup
New York
$10K -$16.1K -1,953 -58%
FDCDDQ
48
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.55K +$7.41K +900 New
AIP
49
Ameritas Investment Partners
Nebraska
$5K – – –
JMF
50
Johnson Midwest Financial
Iowa
$5K – – –
1
2
3

LOGC Hedge Fund Activity: Q1 2021 in Review

61 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q1 2021, worth a combined $128M — down 3.3% from $133M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LOGC positions and 9 closed out — a net gain of 3 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $913K. The largest seller was EcoR1 Capital, cutting an estimated $710K.

  • 61 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q1 2021, up from 59 in Q4 2020.
  • Funds reported $128M of LogicBio Therapeutics, Inc. Common Stock stock for Q1 2021, down 3.3% quarter-over-quarter.
  • 12 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q1 2021 and 9 closed out, a net change of +3 holders.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q1 2021 was GSA Capital Partners, an estimated $913K added.
  • The largest LogicBio Therapeutics, Inc. Common Stock seller in Q1 2021 was EcoR1 Capital, an estimated $710K sold.

Based on aggregated 13F filings for Q1 2021.